फार्मास्यूटिकल्स

Researchers from Australia have reported positive results from a Phase II clinical trial of a new carbohydrate-based drug for treating sepsis. The trial, involving 180 patients in China, demonstrated the drug's ability to reduce the condition's severity. This development offers hope for the first targeted therapy against a leading cause of global deaths.

17 जनवरी 2026 AI द्वारा रिपोर्ट किया गया

दिल्ली हाई कोर्ट ने 12 जनवरी को एक फैसले में जायडस लाइफसाइंसेज को वैश्विक दवा कंपनी ब्रिस्टल मायर्स-स्क्विब के कैंसर ड्रग नivolumab का बायोसिमिलर वर्जन बनाने और बेचने की अनुमति दी है। यह फैसला भारत में कैंसर मरीजों के लिए सस्ती इम्यूनोथेरेपी उपचारों का रास्ता खोल सकता है। नivolumab कई प्रकार के कैंसर के खिलाफ प्रभावी है और इसका पेटेंट मई 2026 में समाप्त हो रहा है।

Egypt's Minister of Health and Population, Khaled Abdel Ghaffar, held an expanded meeting on Monday with representatives of relevant state bodies to discuss ways to support pharmaceutical manufacturers and draft a comprehensive policy framework for boosting local production and localizing biopharmaceutical and biological products.

19 दिसंबर 2025 AI द्वारा रिपोर्ट किया गया

Daiichi Sankyo announced it will begin over-the-counter sales of the emergency contraceptive Norlevo on February 2, marking the first time such a pill is available without a prescription in Japan. The pill must be taken in the presence of a trained pharmacist for safety reasons.

Chile's Public Health Institute warned of two new risks linked to leuprorelina-containing drugs, used for advanced prostate cancer treatment. These include liver issues like fatty liver and severe skin reactions that can be fatal. The review drew from international evidence, with no local cases reported in the past 12 years.

02 दिसंबर 2025 AI द्वारा रिपोर्ट किया गया

The RD Saúde group, owner of the Raia and Drogasil chains, obtained a license to produce and sell over 20 molecules of over-the-counter medicines starting in 2026. The initiative was announced during the RD Day in São Paulo. The products will be launched under the Bwell brand.